Rucher Guillaume, Prigent Kevin, Simard Christophe, Frelin Anne-Marie, Coquemont-Guyot Maëlle, Elie Nicolas, Delcroix Nicolas, Perzo Nicolas, Guinamard Romain, Berger Ludovic, Manrique Alain
Normandie Univ, UNICAEN, UR 4650 PSIR, GIP Cyceron, 14000 Caen, France.
Department of Nuclear Medicine, CHU de Caen, 14000 Caen, France.
J Clin Med. 2023 Sep 8;12(18):5854. doi: 10.3390/jcm12185854.
Thoracic radiation therapy may result in accelerated atherosclerosis and in late aortic valve stenosis (AS). In this study, we assessed the feasibility of inducing radiation-induced AS using a targeted aortic valve irradiation (10 or 20 Grays) in two groups of C57Bl6/J (WT) and ApoE mice compared to a control (no irradiation). Peak aortic jet velocity was evaluated by echocardiography to characterize AS. T2*-weighted magnetic resonance imaging after injection of MPIO-αVCAM-1 was used to examine aortic inflammation resulting from irradiation. A T2* signal void on valve leaflets and aortic sinus was considered positive. Valve remodeling and mineralization were assessed using von Kossa staining. Finally, the impact of radiation on cell viability and cycle from aortic human valvular interstitial cells (hVICs) was also assessed. The targeted aortic valve irradiation in ApoE mice resulted in an AS characterized by an increase in peak aortic jet velocity associated with valve leaflet and aortic sinus remodeling, including mineralization process, at the 3-month follow-up. There was a linear correlation between histological findings and peak aortic jet velocity (r = 0.57, < 0.01). In addition, irradiation was associated with aortic root inflammation, evidenced by molecular MR imaging ( < 0.01). No significant effect of radiation exposure was detected on WT animals. Radiation exposure did not affect hVICs viability and cell cycle. We conclude that targeted radiation exposure of the aortic valve in mice results in ApoE, but not in WT, mice in an aortic valve remodeling mimicking the human lesions. This preclinical model could be a useful tool for future assessment of therapeutic interventions.
胸部放射治疗可能会导致动脉粥样硬化加速以及晚期主动脉瓣狭窄(AS)。在本研究中,我们评估了在两组C57Bl6/J(野生型,WT)小鼠和载脂蛋白E(ApoE)小鼠中使用靶向主动脉瓣照射(10或20格雷)诱导放射性AS的可行性,并与对照组(未照射)进行比较。通过超声心动图评估主动脉峰值射流速度以表征AS。注射MPIO-αVCAM-1后进行T2加权磁共振成像,以检查照射引起的主动脉炎症。瓣膜小叶和主动脉窦上的T2信号缺失被视为阳性。使用冯·科萨染色评估瓣膜重塑和矿化。最后,还评估了辐射对人主动脉瓣膜间质细胞(hVICs)的细胞活力和细胞周期的影响。在3个月的随访中,ApoE小鼠的靶向主动脉瓣照射导致了AS,其特征为主动脉峰值射流速度增加,伴有瓣膜小叶和主动脉窦重塑,包括矿化过程。组织学结果与主动脉峰值射流速度之间存在线性相关性(r = 0.57,P < 0.01)。此外,分子磁共振成像证明照射与主动脉根部炎症相关(P < 0.01)。在WT动物中未检测到辐射暴露的显著影响。辐射暴露不影响hVICs的活力和细胞周期。我们得出结论,小鼠主动脉瓣的靶向辐射暴露在ApoE小鼠而非WT小鼠中导致了模仿人类病变的主动脉瓣重塑。这种临床前模型可能是未来评估治疗干预措施的有用工具。